MassHealth Listening Sessions

UMass Chan Medical School is inviting providers to participate in an upcoming listening session as part of the Centers for Medicare and Medicaid Services (CMS) required behavioral health Mid-Point Assessment for the current 1115 Demonstration. These sessions offer a valuable opportunity to provide feedback on the progress of the Substance Use Disorder (SUD) Demonstration milestones and the Serious Mental Illness/Serious Emotional Disturbance (SMI/SED) Demonstration milestones.

Substance Use Disorder (SUD)

Your input is critical in helping us understand what’s working, what needs improvement, and how to better serve MassHealth members with SUDs through the Demonstration. Topics will include:

  • Access to critical levels of care for opioid use disorder (OUD) and other SUDs
  • Use of evidence-based, SUD-specific patient placement criteria
  • Use of nationally recognized SUD-specific program standards to set provider qualifications for residential treatment facilities
  • Sufficient provider capacity at critical levels of care including for medication assisted treatment for OUD
  • Implementation of comprehensive treatment and prevention strategies to address opioid abuse and OUD
  • Improved care coordination and transitions between SUD levels of care

Session Details:

Serious Mental Illness/Serious Emotional Disturbance (SME/SED)

Your input is critical in helping us understand what’s working, what needs improvement, and how to better serve MassHealth members with SMI or SED through the Demonstration. Topics will include:

  • Quality of care in psychiatric hospitals and residential settings
  • Care coordination and transitions to community-based care
  • Access to crisis stabilization and the full continuum of mental health service
  • Early identification and engagement in treatment for mental health

Session Details:

Your voice is essential to ensure that the behavioral health system continues to meet the needs of our communities. Please join us in this important conversation!

For questions or additional information, contact Sue Pfefferle at [email protected].